Home » Shire Closer to US Approval for Firazyr
Shire Closer to US Approval for Firazyr
Pharmaceutical firm Shire Plc said it was a step closer to receiving U.S. approval for its Firazyr drug to treat hereditary angioedema after positive results from the largest Phase III trial.
London South East
London South East
Upcoming Events
-
07May
-
14May
-
30May